We are live on ! Find out more
LBA

Letko, Brosseau & Associates Portfolio holdings

AUM $6.77B
1-Year Est. Return 38.11%
This Fund
S&P 500
This Quarter Est. Return
+14.88%
1 Year Est. Return
+38.11%
3 Year Est. Return
+83.35%
5 Year Est. Return
+109.01%
10 Year Est. Return
+317.99%
AUM
$5.55B
AUM Growth
+$508M
Cap. Flow
-$116M
Cap. Flow %
-2.08%
Top 10 Hldgs %
33.64%
Holding
105
New
4
Increased
21
Reduced
62
Closed
8

Top Buys

Rank Stock Value
1
EFXT
Enerflex
EFXT
+$40.9M
2
FDX icon
FedEx
FDX
+$25.6M
3
GSK icon
GSK
GSK
+$21.1M
4
RCI icon
Rogers Communications
RCI
+$18.2M
5
SAVE
Spirit Airlines, Inc.
SAVE
+$9.45M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$25.4M
2
CVE icon
Cenovus Energy
CVE
+$24.7M
3
MRK icon
Merck
MRK
+$21.1M
4
CNQ icon
Canadian Natural Resources
CNQ
+$20.9M
5
SBS icon
Sabesp
SBS
+$19M

Sector Composition

Rank Sector Weight
1 Financials 29.2%
2 Communication Services 16.02%
3 Energy 12.23%
4 Materials 11.6%
5 Technology 9.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPR
76
DELISTED
Spirit AeroSystems
SPR
$15.4M 0.28%
519,620
-140,925
-21% -$3.66M
BAP icon
77
Credicorp
BAP
$29.9B
$14M 0.25%
103,250
+9,000
+10% +$1.28M
PROF
78
Profound Medical
PROF
$218M
$12.6M 0.23%
1,180,425
-75,250
-6% -$410K
XBI icon
79
State Street SPDR S&P Biotech ETF
XBI
$10.6B
$6.47M 0.12%
+78,000
New +$6.31M
YTRA icon
80
Yatra Online
YTRA
$72.3M
$5.27M 0.1%
2,188,020
– –
PDS
81
Precision Drilling
PDS
$1.11B
$4.81M 0.09%
62,812
-5,528
-8% -$399K
WBD icon
82
Warner Bros
WBD
$70.5B
$2.67M 0.05%
281,420
-286,817
-50% -$3.24M
SCHW
83
Charles Schwab
SCHW
$186B
$1.82M 0.03%
21,846
– –
VT icon
84
Vanguard Total World Stock ETF
VT
$81B
$1.06M 0.02%
12,325
– –
MET icon
85
MetLife
MET
$61.7B
$937K 0.02%
12,949
-150
-1% -$10.7K
ING icon
86
ING
ING
$105B
$853K 0.02%
70,060
-21,190
-23% -$230K
ENB icon
87
Enbridge
ENB
$104B
$416K 0.01%
10,650
– –
DUK icon
88
Duke Energy
DUK
$93.1B
$319K 0.01%
3,100
– –
FTS icon
89
Fortis
FTS
$27.8B
$295K 0.01%
7,375
– –
OM icon
90
Outset Medical
OM
$60.3M
$293K 0.01%
757
-743
-50% -$210K
KMB icon
91
Kimberly-Clark
KMB
$33B
$275K 0.01%
2,025
– –
GOOGL icon
92
Alphabet (Google) Class A
GOOGL
$4.27T
$244K ﹤0.01%
2,760
– –
REPL icon
93
Replimune Group
REPL
$1.24B
$205K ﹤0.01%
7,525
-15,275
-67% -$317K
CVE.WS
94
DELISTED
Cenovus Energy Inc Warrants
CVE.WS
$194K ﹤0.01%
15,254
– –
BLU
95
DELISTED
BELLUS Health Inc.
BLU
$132K ﹤0.01%
+16,000
New +$149K
MDNA
96
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$77.9K ﹤0.01%
170,000
+70,000
+70% +$42.8K
ATRA icon
97
Atara Biotherapeutics
ATRA
$94.2M
$57.4K ﹤0.01%
700
+72
+11% +$7.5K
FLR icon
98
Fluor
FLR
$7.16B
– –
-270,520
Closed -$6.73M
HRTX icon
99
Heron Therapeutics
HRTX
$59.9M
– –
-57,200
Closed -$241K
NUE icon
100
Nucor
NUE
$58.9B
– –
-2,150
Closed -$230K
1 2 3
4
5

Similar funds

JWBC
John W. Bristol & Co New York $6.76B AUM 18.39% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CAI
Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
LIP
Liontrust Investment Partners London, United Kingdom $6.8B AUM 23.31% 1-Year Est. Return

Letko, Brosseau & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Letko, Brosseau & Associates held 105 positions worth $5.55B, up 10% from $5.04B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Letko, Brosseau & Associates's Q4 2022 filing shows 4 new, 21 increased, 62 reduced and 8 closed positions. Its largest new stake was Enerflex: 7,046,611 shares worth $44.4M. The largest sale was Gilead Sciences, an estimated $25.4M.

By sector, the portfolio is most concentrated in Financials at 29% of assets, down from 30% a quarter earlier, followed by Communication Services and Energy.

  • Letko, Brosseau & Associates's largest Q4 2022 buy was Enerflex: 7,046,611 shares worth $44.4M.
  • Letko, Brosseau & Associates added most to GSK in Q4 2022, an estimated $21.1M increase.
  • Letko, Brosseau & Associates's biggest Q4 2022 reduction was Gilead Sciences, cutting an estimated $25.4M.
  • Letko, Brosseau & Associates fully exited Fluor in Q4 2022, selling an estimated $6.73M.
  • Letko, Brosseau & Associates's ten largest holdings make up 34% of its $5.55B portfolio in Q4 2022.
  • Letko, Brosseau & Associates opened 4 new positions and closed 8 in Q4 2022.
  • Letko, Brosseau & Associates's portfolio value rose 10% quarter-over-quarter to $5.55B.

Based on Letko, Brosseau & Associates's 13F filing for Q4 2022, filed 10 Feb 2023.